Skip to Content

CL10 6 mg (Rivastigmine Tartrate 6 mg)

Pill with imprint CL10 6 mg is Orange / Red, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL10 6 mg

Rivastigmine Tartrate

Imprint
CL10 6 mg
Strength
6 mg
Color
Orange / Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0092

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.